News tagged ‘Leukemia’ clear
- Dr. Matthew Davids has been selected as a recipient of The Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine award, created by Harvard Medical School to support the projects of junior faculty members.
Tags: Honors, Leukemia
- An experimental therapy that tweaks a leukemia patient’s immune cells to recognize an often-deadly form of leukemia has resulted in remission in five adults. Dr. Richard Stone and Dana-Farber will be part of a larger study of the novel approach.
- An experimental therapy that tweaks a leukemia patient's immune cells to recognize an often-deadly form of leukemia has resulted in remission in five adults. Dr. Richard Stone explained that cancer cells are similar enough to normal cells that the T-cells cannot recognize the cancer cells. By injecting genes into the T cells, the immune system is educated to recognize the cancer.
- People recently gathered at St. James Armenian Church in Watertown to support Sarkis Chekijian, who is running the Boston Marathon to raise research funds for Dana-Farber.
- Dr. David Steensma says new genomic studies cataloging the mutations that drive two deadly cancers is a landmark that will stand the test of time.
Tags: Genomics, Leukemia
- Dr. Richard Stone discusses how mutations in a gene involved in the production of white blood cells may improve the diagnosis — and perhaps treatment — of two rare blood cancers.
Tags: Genetics, Leukemia
- The Leukemia & Lymphoma Society (LLS) recently joined Dana-Farber to establish a network of sites for clinical trial testing of innovative blood cancer therapies in community oncology settings.
Tags: BasicResearch, Leukemia